Published in Women's Health Weekly, May 15th, 2008
"Obtaining fetal nucteic material for molecular analysis without the need of invasive procedures has been a goal of prenatal diagnosis for many years; this is now been made possible by the use of non-cellular fetal nucteic acids circulating in maternal blood. The placenta is the primary source of these nucteic acids, raising the possibility that they could be a marker for pregnancy complications resulting from placental....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.